MEDICAL ADVOCATES
IDUs
  HCV European Studies
 
Regional
Belgium 
Bosnia and Herzegovina

Bulgaria

Croatia
Cyprus
France
Germany
Greece
Hungary
Ireland
 
Italy                          Turkey
Lithuania                  United Kingdom
Luxembourg
Montenegro
The Netherlands
Norway
Portugal
Romania
Spain
Sweden
Switzerland
 

IDU HCV National Studies Main New/Newsworthy  Home Page

Last Update:  August 08, 2017
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


Regional/Multinational
       

          Journal Papers, Abstracts, and Commentaries
 
 
Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.
Luhmann N, Champagnat J, Golovin S, et al
Int J Drug Policy
. 2015 Aug 22.
Abstract

FULL-TEXT ARTICLE
A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.
Lazarus JV, Sperle I, Maticic M, Wiessing L.
BMC Infect Dis. 2014 Sep 19;14(Suppl 6):S16
Paper

FULL-TEXT ARTICLE
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.
Wiessing L, Likatavicius G, Hedrich D, et al

Euro Surveill
. 2011 Dec 1;16(48).
Paper


Belgium
       

          Journal Papers, Abstracts, and Commentaries
 
 
The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.
Matheď C, Van Dooren S, Lemey P,  et al
J Viral Hepat. 2008 Jan 28
Abstract

Bosnia and Herzegovina
           

            Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H, Bajramović A, Obradović Z, Mahmić-Kaknjo M.

Med Glas (Zenica)
. 2017 Feb 1;14(1):73-78.
Paper
 

Bulgaria
       


          Journal Papers, Abstracts, and Commentaries
 
  Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users.
Ciccozzi M, Zehender G, Cento V, et al

J Med Virol
. 2011 Sep;83(9):1565-70.

Abstract

Croatia
       

          Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis C Virus Infection and Related Risk Factors among Injection Drug Users in Montenegro.
Baćak V, Laušević D, Mugoša B, et al

Eur Addict Res
. 2012 Sep 19;19(2):68-73.
Abstract

Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and
in therapeutic community in Brod-Posavina County, Croatia].
Kolovrat A, Jurisić I, Marić Z, Cvitković A.
Acta Med Croatica. 2010 Oct;64(4):287-96.
Abstract


Cyprus
       

          Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL, van de Vijver DA, Hezka J, et al

J Med Virol
. 2010 Feb;82(2):263-270.

Abstract

France
       

          Journal Papers, Abstracts, and Commentaries
 
  Positive impact of HCV treatment on ART adherence in HIV-HCV coinfected patients: one more argument for expanded access
to HCV treatment for IDUs.
Roux P, Fugon L, Winnock M, Salmon-Céron D, et al  
Addiction
. 2011 Aug 5

Abstract

Germany
       

          Journal Papers, Abstracts, and Commentaries
 
 
Natural prevalence of resistance-associated variants in hepatitis C virus NS5A in genotype 3a-infected people who inject drugs in Germany
Walker A, Siemann H, Groten S,
J Clin Virol. 2015 Sep;70:43-5.
Abstract

FULL-TEXT PDF ARTICLE
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany, using respondent driven sampling.
Zimmermann R, Marcus U, Schäffer D, et al

BMC Public Health
. 2014 Aug 14;14(1):845

Paper

Transmission of Hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.
Doerrbecker J, Behrendt P, Mateu-Gelabert P,  et al
J Infect Dis. 2012 Nov 5
Abstract

Prevention of hepatitis C virus infection in drug users.
Schulte B, Stöver H, Leicht A, et al

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1210-7.
Abstract


Greece
       


          Journal Papers, Abstracts, and Commentaries
 
  HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
Papachristou E, Tsagovits A, Zavitsanou A,
Infect Genet Evol. 2016 Oct 6.
Abstract

Should active injecting drug users receive treatment for chronic hepatitis C?
Papadopoulos V, Gogou A, Mylopoulou T, Mimidis K.
Arq Gastroenterol. 2010 Sep;47(3):238-41
Abstract


Hungary
       

          Journal Papers, Abstracts, and Commentaries
 
 
Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users.]
Gyarmathy VA, Rácz J.

Orv Hetil
. 2011 Jan 1;152(4):124-130
Abstract

Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G, Horvath G, Szabo O, Ungvari GS.

Neuropsychopharmacol Hung
. 2010 Dec;12(4):459-62.
Abstract

Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug
users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.
Gyarmathy VA, Neaigus A, Li N,  et al

Scand J Infect Dis
. 2010 Sep 15
Abstract


Ireland
       


          Journal Papers, Abstracts, and Commentaries
 
 

FULL-TEXT ARTICLE
Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
Elsherif O, Bannan C, Keating S,  et al

PLoS One
. 2017 Jun 21;12(6):e0178398

Paper

Methadone and HCV treatment.
McCormick PA, Keavney M, O'Toole S, Moloney J.
Ir Med J. 2008 Nov-Dec;101(10):316-7
Abstract


Italy
       

          Journal Papers, Abstracts, and Commentaries

 
HCV RNA levels in a multi-ethnic cohort of injection drug users: Human genetic, viral and demographic associations.
Uccellini L, Tseng FC, Monaco A,  et al
Hepatology. 2012 Feb 13.
Abstract 

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population
groups (migrants,

intravenous drug users and prison inmates).
Almasio PL, Babudieri S, Barbarini G,  et al
Dig Liver Di
s
. 2011 Jan 20
Abstract 


Lithuania
       

          Journal Papers, Abstracts, and Commentaries
 
 
Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug
users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.
Gyarmathy VA, Neaigus A, Li N,  et al

Scand J Infect Dis
. 2010 Sep 15
Abstract

Luxembourg
       

          Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT PDF ARTICLE
A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in
Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S,  et al
BMC Public Health
. 2011 May 19;11(1):351.
Paper

Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg:
self-report versus serological evidence.
Origer A, Schmit JC.
J Epidemiol Community Health. 2010 Oct 1
Abstract


Montenegro
       

          Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
Mugosa B, Cella E, Lai A, et al.
Arch Virol. 2017 Feb 13.

Abstract

The Netherlands
       

          Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.
van Santen DK, de Vos AS, Matser A,  et al
PLoS One
. 2016 Oct 6;11(10):e0163488.
Paper

BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion.
Grady BP, Prins M, Rebers S,  et al
J Viral Hepat
. 2014 Sep 1.
Abstract

Hepatitis C virus reinfection following treatment among people who use drugs.
Grady BP, Schinkel J, Thomas XV, Dalgard O.
Clin Infect Dis. 2013 Aug;57 Suppl 2:S105-10.
Abstract

Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
de Vos AS, van der Helm JJ, Matser A,  et al

Addiction
. 2013 Jan 24.
Abstract

The effect of hepatitis C treatment and HIV coinfection on the disease burden of hepatitis C among
injecting drug users in Amsterdam.
Matser A, Urbanus A, Geskus R,  et al

Addiction
. 2011 Sep 15.
Abstract

Seroprevalence of HIV, hepatitis B, and hepatitis C among opioid drug users on methadone
treatment in the Netherlands.

Schreuder I, van der Sande MA, de Wit M, et al

Harm Reduct J
. 2010 Oct 26;7(1):25.
Abstract

 

          Conference Reports, Abstracts, and Posters
 
 
Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: evidence for harm reduction?
A.S. de Vos, J.J. van der Helm, M. Prins, et al
(XIX nternational AIDS Conference)
Abstract

Norway
       

          Journal Papers, Abstracts, and Commentaries
 

  FULL-TEXT ARTICLE
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
Meijerink H, White RA, Lřvlie A

BMC Infect Dis. 2017 Aug 3;17(1):541..
Paper

Hepatitis C Reinfection Following Sustained Virological Response - Seven-Year Follow-Up Of Patients Infected Through Injecting Drug Use
Midgard H, Bjřro B, Mćland A,  et al
J Hepatol
. 2016 Jan 9.
Abstract 

HCV treatment uptake in people who have injected drugs - observations in a large cohort that received addiction treatment 1970-1984.
Kielland KB, Amundsen EJ, Dalgard O.
Scand J Gastroenterol
. 2014 Oct 13:1-8
Abstract 

All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
Kielland KB, Skaug K, Amundsen EJ, Dalgard O.

J Hepatol
. 2012 Sep 4.
Abstract 


Portugal
       

          Journal Papers, Abstracts, and Commentaries
 
 
Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV.
Silva T, Cortes Martins H,  et a
L
J Med Virol
. 2015 May 1.

Abstract

Romania
       

          Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
HCV non-1b genotypes in injecting drug users from Romania.
Ruta S, Sultana C, Oprea C, et al
J Infect Dev Ctries. 2016 May 31;10(5):523-7
Paper

Spain
       

          Journal Papers, Abstracts, and Commentaries
 
  Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.
Roncero C, Littlewood R, Vega P,  et al
Eur J Gastroenterol Hepatol
. 2017 Feb 22.
Abstract

Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.
Fernŕndez-López L, Folch C, Majó X,  et al
 
AIDS Care
. 2016 Mar 23
Abstract

High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes
Vallejo F, Barrio G, Brugal MT,  et al

J Epidemiol Community Health
. 2015 Jun;69(6):599-603
Abstract

High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F, Barrio G, Brugal MT, et al
J Epidemiol Community Health
. 2015 Apr 13.
Abstract


Sweden
       

          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.
Danielsson A, Palanisamy N, Golbob S,  et al
Infect Ecol Epidemiol
. 2014 Jan 15;4
Paper

Hepatitis C Among Injecting Drug Users Is Two Times Higher in Stockholm, Sweden than in Rotterdam, the Netherlands.
Norden L, van Veen M, Lidman C,  et al

Subst Use Misuse
. 2013 Jun 10
Abstract

Hepatitis C infection among injection drug users in Stockholm Sweden: Prevalence and gender.
Lidman C, Norden L, Kĺberg M, et al

Scand J Infect Dis
. 2009 Jun 11:1-6
Abstract


Switzerland
       

      Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
Management of hepatitis C virus (HCV) infection in drug substitution programs.
Witteck A, Schmid P, Hensel-Koch K,  et al
Swiss Med Wkly
. 2011 May 27;141:w13193
Paper

Management of hepatitis C virus (HCV) infection in drug substitution programs.
Witteck A, Schmid P, Hensel-Koch K,  et al
Swiss Med Wkly
. 2011 May 27;141:w13193.

Abstract
 


Turkey
       

          Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
Hepatitis C Infection and Other Drug Related Harms Among Inpatients Who Injected Drugs in Turkey.
Alaei A, Alaei K, Waye K, Tracy M, et al
J Viral Hepat
. 2016 Dec 7.

Paper

United Kingdom
       

          Journal Papers, Abstracts, and Commentaries
 

 
Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15.
Hope VD, McVeigh J, Smith J,  et al
Drug Alcohol Depend. 2017 Jul 18;179:83-86.
Abstract


Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
Stone J, Martin NK, Hickman M, et al

Addiction
. 2017 Mar 3.
Abstract

Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: results from cross-sectional prevalence surveys, 1992-2013.
Hope VD, Harris R, McVeigh J,  et al
J Acquir Immune Defic Syndr. 2015 Sep 8
Abstract

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.
Hutchinson SJ, Dillon JF, Fox R,  et al
Int J Drug Policy
. 2015 Jun 6.
Abstract

FULL-TEXT ARTICLE
Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections.
Bennett H, McEwan P, Sugrue D,  et al

PLoS One
. 2015 May 4;10(5):e0125846
Paper

FULL-TEXT ARTICLE
Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) - Vietnam, 2009-2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus.
Nadol P, O'connor S, Duong H, et al

PLoS One
. 2015 Feb 18;10(2):e0118304.
Paper

Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.
Prevost TC, Presanis AM, Taylor A,  et al
Addiction. 2015 Apr 14.
Abstract

Screening for Hepatitis C in injecting and ex-injecting drug users in North East Essex.
Bishton E, Oluboyede F, Grylls E, Woods L, Thomas S.

Public Health
. 2014 Nov;128(11):1036-8.
Abstract

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.
Martin NK, Foster GR, Vilar J,  et al
J Viral Hepat
. 2014 Oct 7. d
Abstract

FULL-TEXT PDF ARTICLE
Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions.
Palmateer NE, Taylor A, Goldberg DJ,  et al

PLoS One
. 2014 Aug 11;9(8):e104515
Paper

Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.
Cullen KJ, Hope VD, Croxford S,  et al 
Epidemiol Infect. 2014 Aug 14:1-10.
Abstract

Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
Palmateer N, Hutchinson S, McAllister G,  et al

J Viral Hepat
. 2014 Jan;21(1):25-32.
Abstract

FULL-TEXT ARTICLE
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons.
Martin NK, Hickman M, Miners A, et al
BMJ Open
. 2013 Aug 13;3(8).
Paper

Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods.
McDonald SA, Hutchinson SJ, Schnier C,  et al

Epidemiol Infect
. 2013 Mar 22:1-8.
Abstract

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland.
McDonald SA, Hutchinson SJ, Palmateer NE,  et al

J Hepatol
. 2012 Nov 10
Abstract

Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ, Palmateer NE, Hutchinson SJ,  et al
Int J Drug Policy. 2012 Aug 31
Abstract

Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
Marongiu A, Hope VD, Parry JV, Ncube F.

Sex Transm Infect. 2012 May 23.
Abstract

Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.
Sutton AJ, McDonald SA, Palmateer N,  et al

Epidemiol Infct
. 2012 Mar 30:1-9.
Abstract

Hepatitis C infection among recent initiates to injecting in England 2000-2008:
Is a national hepatitis C action plan making a difference?
Hope V, Parry JV, Marongui A, Ncube F.
J Viral Hepat. 2012 Jan;19(1):55-64
Abstract

Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based
case-finding intervention.
Cullen BL, Hutchinson SJ, Cameron SO,  et al
J Public Health (Oxf). 2011 Dec 2
Abstract

Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings-
Implications for intervention impact.
Vickerman P, Martin NK, Hickman M.
Drug Alcohol Depend. 2011 Dec 2
Abstract

FULL-TEXT ARTICLE
Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users.
Martin NK, Pitcher AB, Vickerman P, et al

PLoS One
. 2011;6(8):e22309.
Paper

The impact of needle and syringe provision and opiate substitution therapy on the incidence
of Hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner K, Hutchinson S, Vickerman P, et al

Addiction
. 2011 May 25.
Abstract

Loss of Virus-specific T-Cell Responses in HCV Exposed Uninfected Injection Drug Users With
Drug Rehabilitation.
Thurairajah PH, Hegazy D, Demaine A, et al

J Infect Dis
. 2011 Mar;203(6):847-53|
Abstract

The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting
drug user population.
McDonald SA, Hutchinson SJ, Mills PR, et al

J Viral Hepat
. 2010 Oct 22
Abstract

Visual Versus Written Cues: A Comparison of Drug Injectors' Responses. Have
Surveys Using the Written Word Underestimated Risk Behaviors for Hepatitis C?
Beynon CM, Taylor A, Allen E, Bellis MA.

Subst Use Misuse
. 2010 May 3.
Abstract


IDU HCV National Studies Main New/Newsworthy  Home Page

IDU Hepatitis C European Studies